Oliver Lagore Vanvalin Investment Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-40
Closed -$13.3K 766
2024
Q1
$13.3K Hold
40
﹤0.01% 382
2023
Q4
$10.8K Hold
40
﹤0.01% 399
2023
Q3
$9.84K Hold
40
﹤0.01% 444
2023
Q2
$12.1K Hold
40
﹤0.01% 438
2023
Q1
$10.5K Hold
40
﹤0.01% 381
2022
Q4
$9.6K Hold
40
0.01% 367
2022
Q3
$7K Hold
40
﹤0.01% 387
2022
Q2
$7K Hold
40
﹤0.01% 375
2022
Q1
$10K Buy
+40
New +$10K 0.01% 335

Other funds holding HCA

Oliver Lagore Vanvalin Investment Group's HCA Position: Q2 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of HCA Healthcare (HCA) in Q2 2024, closing a stake of 40 shares — an estimated $13.3K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in HCA in Q1 2022 and held it in 9 quarters. The position peaked at $13.3K in Q1 2024. 1,156 funds tracked by Wall St. Rank hold HCA as of Q2 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining HCA Healthcare position as of Q2 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 40 HCA Healthcare shares in Q2 2024, an estimated $13.3K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in HCA Healthcare in Q1 2022 and held it in 9 quarters.
  • Oliver Lagore Vanvalin Investment Group's HCA Healthcare position peaked at $13.3K in Q1 2024.
  • 1,156 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2024, filed 15 Aug 2024.